
    
      This is an open-label (volunteers will know the names of treatments they are assigned)
      single-center study of SP2086 and Simvastatin in healthy adult volunteers. SP2086 will be
      administered orally (by mouth) as 100 mg on Days 4, 5, 6, 7, and 8 and Simvastatin will be
      administered orally as two 20mg tablets on Days 1 and 8. Both SP2086 and Simvastatin tablets
      will be taken with 8 ounces (240 mL) of water.
    
  